en

PRODUCT DETAIL

Icatibant Accord 30 mg injekčný roztok v naplnenej injekčnej striekačke

Code 8217D
MA number EU/1/21/1567/002
Product Form: sol inj 3x3 ml/30 mg (striek.inj.napl.skl.+3 ihly)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 87 - VARIA I
ATC:
B BLOOD AND BLOOD FORMING ORGANS
B06 OTHER HEMATOLOGICAL AGENTS
B06A OTHER HEMATOLOGICAL AGENTS
B06AC Drugs used in hereditary angioedema
B06AC02 Icatibant
Shelf life: 24
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 16.07.2021
Validity: 16.07.2026
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 11.08.2021
eu-flag.png sk-flag.png